Later Greenbaum and his team [30] demonstrated that a high level of HS2 transcription in colon and pancreatic cancers correlated with low levels of CD8 + lymphocytes and poor prognosis, while a low level of HS2 transcription was associated with a better prognosis in solid cancers. This evidence concerns the gene CD8A and familial pancreatic carcinoma.